Specific life consequences correlated to symptoms attributed to benzodiazepine use.

NIAID Data Ecosystem2026-05-01 收录

数据链接：

https://figshare.com/articles/dataset/Specific_life_consequences_correlated_to_symptoms_attributed_to_benzodiazepine_use_/23604295 数据链接链接失效反馈

官方服务：

资源简介：

A total of 23 symptoms could be selected in the survey. For all life consequences, the average duration of reported symptoms was >1 year.

创建时间：

2023-06-29

Supplementary materials: Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry

特应性皮炎治疗

长期药物安全性评估

Supplementary materials related to the manuscript entitled “Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic derm

Mendeley Data2024-04-22 更新60

Dataset from An Open-label, Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Treatment of Partial-onset Seizures

癫痫药物治疗

长期药物安全性评估

To provide continued treatment of Keppra XR (Levetiracetam XR) and to assess the long term safety of Keppra XR in subjects with partial onset seizures.

NIAID Data Ecosystem20

Dataset from A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) Once Daily Monotherapy to Methotrexate (MTX) Monotherapy in MTX-Naïve Subjects With Moderately to Severely Active Rheumatoid Arthritis

类风湿关节炎药物

长期药物安全性评估

The objectives of Period 1 were the following: - To compare the safety and efficacy of upadacitinib 7.5 mg once daily (QD) monotherapy (for participants in Japan only), 15 mg QD monotherapy, and

NIAID Data Ecosystem20

An Open-label Study of the Safety and Efficacy of Topiramate for Migraine Prophylaxis: Extension Study to CAPSS-277

偏头痛药物临床试验

长期药物安全性评估

The purpose of this study is to assess the long-term safety and effectiveness of topiramate for the prevention of migraine headaches in adults. Topiramate has been approved to prevent migraine headach

DataCite Commons2024-12-02 更新30

Dataset from A Randomized, Double-Blind, Parallel-Group, 52-Week, Chronic-Dosing, Multi-Center Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

COPD药物临床试验

长期药物安全性评估

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

NIAID Data Ecosystem20